Pentair Outlook - A Neutral Stance with Mixed Signals
Market Snapshot
Takeaway: PentairPNR-- (PNR) remains in a technical neutrality phase with mixed analyst ratings, and its recent price has risen by 3.18%.
News Highlights
Recent developments affecting Pentair include shifts in U.S. federal vaccine policy and global economic adjustments. Notably:
- May 31, 2025 - China's factory activity saw a modest improvement with a PMI of 49.5, indicating a slight easing of economic contraction. This could influence global manufacturing demand, indirectly affecting Pentair's industrial products market.
- May 31, 2025 - REX Shares filed for EthereumETH-- and SolanaSOL-- ETFs that stake crypto holdings, potentially impacting broader financial markets. While not directly tied to Pentair, it reflects broader market speculation and capital flows.
- May 31, 2025 - U.S. President Donald Trump fast-tracked a uranium mine in Utah, hinting at a potential revival in the sector. While not directly relevant to Pentair, the move highlights policy-driven market shifts.
Analyst Views & Fundamentals
Analysts show a mixed outlook for Pentair, with a simple average rating of 3.90 and a performance-weighted rating of 3.54. The ratings are inconsistent, with six Buy ratings, one Sell, one Strong Buy, and one Neutral. Despite the varied perspectives, the current price trend of 3.18% aligns with the market's generally neutral expectations.
Key Fundamental Factors
- ROA (Return on Assets): 2.29%, indicating moderate asset efficiency. Internal diagnostic score (0-10): 3
- EV/EBIT: 59.99, suggesting a high valuation relative to earnings. Internal diagnostic score (0-10): 2
- Basic Earnings Per Share (YoY growth rate): -4.66%, reflecting a decline in profitability. Internal diagnostic score (0-10): 3
- Net Assets Per Share (growth rate compared to beginning of year): 3.62%, showing modest growth in equity value. Internal diagnostic score (0-10): 3
- CFOA (Cash Flow from Operating Activities): 9.36%, indicating strong operational cash generation. Internal diagnostic score (0-10): 3
- PE (Price-to-Earnings): 125.64, suggesting high investor expectations. Internal diagnostic score (0-10): 2
Money-Flow Trends
Pentair is experiencing positive fund flow across all categories, with overall inflow ratio of 50.86% and positive trends in large and extra-large flows. This suggests institutional and large investors are increasingly confident in the stock.
- Small flows: 50.39% inflow, positive trend
- Medium flows: 51.55% inflow, positive trend
- Large flows: 49.71% inflow, negative trend
- Extra-large flows: 51.02% inflow, positive trend
- Overall fund flow score: 7.82, a good internal diagnostic score (0-10)
Key Technical Signals
Pentair's technical indicators show mixed signals, with an internal technical score of 5.32, indicating neutrality and a wait-and-see approach is advised.
Indicator Details
- WR Overbought: Score of 3.12, indicating weak signal strength
- MACD Death Cross: Score of 5.76, showing a moderate bearish bias
- MACD Golden Cross: Score of 7.09, suggesting a strong bullish bias
Recent Patterns
- 2025-09-03: MACD Death Cross signal
- 2025-09-04: WR Overbought and MACD Golden Cross signals
- 2025-09-05: WR Overbought signal
- 2025-09-08: WR Overbought signal
- 2025-09-11: WR Overbought signal
Insights
Technical indicators suggest a volatile state with no clear direction. Long and short signals are relatively balanced, and the market is advised to pay close attention to any changes.
Conclusion
With mixed analyst ratings, a neutral technical outlook, and mixed price momentum, Pentair appears to be in a holding pattern. Investors should consider waiting for a clearer trend to emerge before making a move. While fundamentals show moderate strength in some areas, the high PE ratio and weak earnings growth suggest caution. Keep an eye on upcoming earnings and any policy-driven market changes, particularly as they may indirectly influence industrial equipment demand.
A quantitative finance AI researcher dedicated to uncovering winning stock strategies through rigorous backtesting and data-driven analysis.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet